ABRAMETS I I: "Neurophysiological and neurochemical aspects of the effects of antidepressants and mood stabilizers", NEUROPHYSIOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 40, no. 1, 25 June 2008 (2008-06-25), pages 64-78, XP019612457, ISSN: 1573-9007 (B1)

BURGDORF J S ET AL: "The antidepressant and anxiolytic properties of GLYX-13: A novel NMDA receptor glycine site functional partial agonist", ABSTRACTS OF THE ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, WASHINGTON, DC, US, vol. 40, 1 January 2010 (2010-01-01), XP009166603, ISSN: 0190-5295 (B1)

BURGDORF J S ET AL: "Uncovering the molecular basis of positive affect using rough-and-tumble play in rats: A role for the NMDA receptor and implications for depression", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER, vol. 38, 2008, XP009166609, & 38TH ANNUAL MEETING OF THE SOCIETY-FOR-NEUROSCIENCE; WASHINGTON, DC, USA; NOVEMBER 15 -19, 2008 (B1)

Burgdorf et al.: "GLYX-13, an NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects", , 3 December 2012 (2012-12-03), XP002691138, Retrieved from the Internet: URL:http://www.nature.com/npp/journal/vaop /naam/pdf/npp2012246a.pdf [retrieved on 2013-01-29] (B1)

KRYSTAL J H ET AL: "NMDA AGONISTS AND ANTAGONISTS AS PROBES OF GLUTAMATERGIC DYSFUNCTION AND PHARMACOTHERAPIES IN NEUROPSYCHIATRIC DISORDERS", HARVARD REVIEW OF PSYCHIATRY, ST. LOUIS, MO, US, vol. 7, no. 3, 1 January 1999 (1999-01-01) , pages 125-143, XP008048548, ISSN: 1067-3229, DOI: 10.1093/HRP/7.3.125 (B1)

ZHANG ET AL.: 'A NMDA receptor glycine site partial agonist, GLYX-13, that simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.' NEUROPHARMACOLOGY vol. 55, no. 7, 2008, pages 1238 - 1250, XP008156004 (B1)

US-A- 6 107 271 (B1)

US-A1- 2005 037 433 (B1)

US-A1- 2005 118 286 (B1)

US-A1- 2006 241 046 (B1)

WO-A2-02/072609 (B1)

PITTENGER CHRISTOPHER ET AL: "The NMDA receptor as a therapeutic target in major depressive disorder.", CNS & NEUROLOGICAL DISORDERS DRUG TARGETS APR 2007, vol. 6, no. 2, April 2007 (2007-04), pages 101-115, XP009166640, ISSN: 1871-5273 (B1)